An autopsy case of SCA2 with parkinsonian phenotype

Clinical Neurology

Volumn 50, Issue 3, 2010, Pages 156-162

  Yomono, Harumi S ^a   Kurisaki, Hiroshi ^a   Hebisawa, Akira ^a   Sakiyama, Yoshio ^b   Saito, Yuko ^c   Murayama, Shigeo ^d  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c National Center Hospital of Neurology and Psychiatry   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Lewy body pathology; Parkinsonism; SCA2

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ALPHA SYNUCLEIN; HOMOVANILLIC ACID; NUCLEIC ACID BINDING PROTEIN; PROTEIN SCA2; UNCLASSIFIED DRUG; NERVE PROTEIN; SCA2 PROTEIN;

ARTICLE; AUTOPSY; BRAIN ATROPHY; CEREBELLAR ATAXIA; CEREBROSPINAL FLUID; DEMENTIA; DIFFUSE LEWY BODY DISEASE; HUMAN; MEDULLA OBLONGATA; OLIVOPONTOCEREBELLAR ATROPHY; PARKINSONISM; PONS; SUBSTANTIA NIGRA; AGED; BRAIN; CASE REPORT; CHROMOSOME 12; GENETICS; HEART MUSCLE; LEWY BODY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PARKINSON DISEASE; PATHOLOGY; PHENOTYPE; SPINOCEREBELLAR DEGENERATION;

AGED; AUTOPSY; BRAIN; CHROMOSOMES, HUMAN, PAIR 12; HUMANS; LEWY BODIES; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MYOCARDIUM; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PHENOTYPE; SPINOCEREBELLAR DEGENERATIONS;

EID: 77951935739     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.50.156     Document Type: Article

References (15)

1. Hernández A, Magariño C, Gispert S, et al. Genetic mapping of the spinocerebellar ataxia 2 (SCA2) locus on chromosome 12q23-q24.1. Genomics 1995;25:433-435.
2. Fernandez M, McClain ME, Martinez RA, et al. Lateonset SCA2: 33 CAG repeats are sufficient to cause disease. Neurology 2000;55:569-572.
3. Giunti P, Sabbadini G, Sweeney MG, et al. The role of the SCA 2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates. Brain 1998;121:459-467.
4. Gwinn-Hardy K, Chen JY, Liu HC, et al. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology 2000;55:800-805.
5. Kock N. Müller B, Vieregge P, et al. Role of SCA2 mutations in early- and late-onset dopa-responsive parkinsonism. Ann Neurol 2002;52:257-258. (Pubitemid 34810614)
6. Charles P, Camuzat A, Benammar N, et al. Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? Neurology 2007;69:1970-1975.
7. Lu CS, Chou YHW, Kuo PC, et al. The Parkinsonian phenotype of spinocerebellar ataxia type 2. Arch Neurol 2004;61:35-38. (Pubitemid 38067411)
8. Düerr A, Smadja D, Cancel G, et al. Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies) Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 1995;118:1573-1581.
9. Pang JT. Guinti P, Chamberlain S, et al. Neuronal intranuclear inclusions in SCA2: a genetic, morphological and immunohistochemical study of two cases. Brain 2002;125:656-663. (Pubitemid 34194418)
10. 123I- metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease. J Neurol Sci 2006;243:101-104.
11. Probst-Cousin S, Acker T. Epplen J T, et al. Spinocerebellar ataxia type 2 with glial cell cytoplasmic inclusions. J Neurol Neurosurg Psyciatry 2004;75:503-505. (Pubitemid 38338791)
12. Berciano J, Ferrer I. Glial cell cytoplasmic inclusions in SCA2 do not express α-synuclein. J Neurol 2005;252:742-744. (Pubitemid 40864055)